People do not get better on donanemab. It is not a cure for Alzheimer’s disease, but it slows the progression of the disease.
It works by clearing a sticky protein from the brain – called amyloid – which is one of the hallmarks of Alzheimer’s.
The drug was earlier given a licence to be used in the UK, which means it can be prescribed privately.
However, NICE has ruled it would not be a good use of taxpayers’ money and was five-to-six times more expensive than the NHS normally considers acceptable.
It said the drug slowed cognitive decline by four to seven months in trials.
“This is just not enough benefit to justify the additional cost to the NHS,” said Helen Knight, director of medicines evaluation at NICE.
“I know this will be disappointing news, but this is an emerging field of medicine and there are other treatments being developed.”
It is estimated that around 70,000 adults in England would have been eligible for treatment with donanemab.
Nail technician Erin, who missed two years of work during her cancer treatment, also has…
UN teams on the ground reached the families after they were confined to their homes…
According to local authorities, the disease has killed 2,325 people, surpassing the 2,299 deaths recorded…
Whilst in Egypt, Kushner also met Egyptian President Abdel Fattah al-Sisi. According to Israeli media…
The conflict there killed hundreds of thousands of people, displaced millions, and caused severe damage…
Iqra Wasim from Fishponds in Bristol has struggled with PMOS symptoms such as painful acne…